Roche Warns On Anti-Trust Zeal While Posting Painful Q1

But Says Biosimilar Erosion ‘Has Already Hit High Watermark’

 
• By Sten Stovall
Strong Q1 Diagnostics Offset Limp Drug Sales • Source: Alamy

More from Earnings

More from Business